Mersana Therapeutics (MRSN) Announces Positive Interim Data from Expansion Portion of the XMT-1536 Phase 1 Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/4/2026

1. KRG
2. SKA-B
3. PBA
4. ALAR
5. CCH:LN
6. META
7. CCHGY
8. PRY:IM
9. PRYMY
10. SPY

Go back to Mersana Therapeutics (MRSN) Announces Positive Interim Data from Expansion Portion of the XMT-1536 Phase 1 Study

Mersana Therapeutics (MRSN) Prices 8M Share Common Offering at $19/Sh

May 29, 2020 5:54 AM EDT

Mersana Therapeutics, Inc. (NASDAQ: MRSN) today announced the pricing of an underwritten public offering of 8,000,000 shares of common stock at a price to the public of $19.00 per share. Gross proceeds to Mersana from the offering are expected to be $152.0 million, before deducting underwriting discounts and... More